Lumicks, which is developing single-molecule analysis technology based on research at Vrije Universiteit Amsterdam, has collected $93m.
Lumicks, a Netherlands-based single-molecule analysis technology spinout of Vrije Universiteit Amsterdam, has closed a $93m series D round backed by internet and telecommunications group SoftBank’s Vision Fund 2.
The round was co-led by Farallon Capital Management and Lauxera Capital Partners.
It also included funds and accounts advised by T Rowe Price, Parian Global Management, Pura Vida Investments, Irving Investors, existing backer Gilde Healthcare and unnamed members of Lumicks’ management team.
Founded in 2014, Lumicks is developing single-molecule…
